Alterity Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is July - June.

Millions EUR. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 23, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	52	51	13	10	21	37
Market Cap Growth	21.30%	290.02%	25.47%	-49.51%	-44.11%	241.04%
Enterprise Value	28	48	6	-5	-4	15
Last Close Price	0.01	0.00	0.00	0.00	0.00	0.01
PS Ratio	17.20	16.78	5.22	4.36	6.11	13.45
PB Ratio	2.21	2.15	1.52	0.75	0.88	1.92
P/TBV Ratio	2.21	2.15	1.52	0.75	0.88	1.92
EV/Sales Ratio	8.55	15.97	2.22	-	-	5.37
Debt / Equity Ratio	0.00	0.00	0.01	0.01	0.00	0.00
Net Debt / Equity Ratio	-0.95	-0.95	-0.90	-0.68	-0.98	-0.92
Net Debt / EBITDA Ratio	2.77	2.77	0.64	1.07	2.24	1.85
Net Debt / FCF Ratio	3.54	3.54	0.99	0.78	2.79	1.62
Asset Turnover	0.17	0.17	0.17	0.11	0.14	0.20
Quick Ratio	12.62	12.62	3.10	5.58	6.79	10.56
Current Ratio	12.98	12.98	3.54	6.17	7.07	10.92
Return on Equity (ROE)	-43.23%	-43.23%	-104.47%	-47.38%	-38.97%	-81.39%
Return on Assets (ROA)	-28.09%	-28.09%	-52.66%	-26.64%	-25.85%	-43.62%
Return on Capital Employed (ROCE)	-34.50%	-34.50%	-141.60%	-63.80%	-43.60%	-49.70%
Earnings Yield	-12.99%	-13.31%	-91.15%	-80.84%	-41.06%	-26.24%
FCF Yield	-	-12.55%	-60.11%	-117.35%	-39.72%	-29.72%
Buyback Yield / Dilution	-75.31%	-75.31%	-50.29%	-0.91%	-41.79%	-89.62%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.